-+ 0.00%
-+ 0.00%
-+ 0.00%

Xeris Biopharma Holdings FY2030 Revenue expected to be more than 1 Billion up from $750M

Benzinga·11/05/2026 12:04:27
Listen to the news

Xeris Biopharma Holdings (NASDAQ:XERS) FY2030 Revenue expected to be more than 1 Billion up from approximately $750 million.